Desalaninebenanomicin A has been synthesized in good yield by the cleavage of the amido bond of benanomicin A using Meerwein's reagent. This is a useful intermediate to prepare amino acid analogs of benanomicin A. Meerwein's reagent reacts with totally protected benanomicin A to give a stable imino ether. After deprotection, the imino ether is treated with aqueous acetone at reflux to afford a methyl ester of desalaninebenanomicin A. Desalaninebenanomicin A was coupled with a variety of aminoacids by the active ester method to afford newbenanomicinanalogs.
of D-serine to the culture medium.8)
In our studies on benanomicins, our attention was focused on the relationship between the structure of the amino acid moiety and the antifungal activity. Herein, we wish to report the chemical transformation of 1 into new amino acid analogs. Chemistry
Our initial efforts were directed toward preparing desalaninebenanomicin A (6). On acid hydrolysis of 1, the cleavage of glycosidic bonds preceded the amido cleavage.40 Alkaline hydrolysis of 1 gave no desired product. The amido bond was extremely stable under the alkaline condition. Treatment of 1 with diazodiphenylmethane in a mixture of A^AT-dimethylformamide and methanol, followed by the acetylation with acetic anhydride in pyridine afforded nona-0-acetyl-diphenylmethyl ester 2 in a good yield. An excess of Meerwein's reagent (trimethyloxonium tetrafluoroborate is preferable to triethyloxonium tetrafluoroborate for this reaction) smoothly reacted with 2 in dry dichloromethane to yield a stable methyl imino ether-diphenylmethyl ester 3a along with methyl ester 3b and carboxylic acid 3c. XHNMRspectrum of 3a showedthe presence of a new methoxy group. Alkaline hydrolysis of a mixture of 3a~3c with 1 M sodium hydroxide at room temperature, followed by the acidification gave an orange powder ofbenanomicin A methyl imino ether (4). On refluxing 4 in aqueous acetone for 3 hours, desalaninebenanomicin A methyl ester (5) was obtained in 44% yield from 1. By the hydrolysis with hydrochloric acid, imino ether 4 reverted to amido 1. *H NMRspectrum of 5 revealed the presence of an aromatic methyl ester at S 3.82. The negative FAB-MSof 5 showed a parent peak at m/z 770. The methyl ester 5 was hydrolyzed with 2m sodium hydroxide at 70°C gave 6, which was an important key potassium carbonate and chromatographed on silica gel to give new benanomicin analogs 8. (Fig. 1) The reduction of 4 with sodium borohydride in an aqueous ethanol gave 15-deoxobenanomicin A (9). XHNMRof9 hydrochloride in DMSO-J6revealed a singlet methylene signal at S 4.22. In 13C NMR, a new methylene carbon instead of the amido carbon at C-15 position was observed at 5 43.3.
In Vitro Antifungal Activity Minimum inhibitory concentrations (MICs) of new benanomicin analogs, 8a, 8b, 8c, 8d, 8e, 8f, 8g, 8j and 81 against various fungi are summarized in Table 1 . The D-amino acid analogs retain the antifungal activity.
The L-amino acid analogs, 8a, 8d and 8e, are essentially devoid of antifungal activity.
D-Allothreonine (D-aThr) and D-butyrine analogs, 8c and 8g respectively, are slightly less active than 1. Interestingly, 8c is superior to D-threonine analog, 8b. However, D-phenylalanine analog, 8h, markedly decreases the antifungal activity. Aminomalonicacid analog, 8j, which has no asymmetric center in the amino acid moiety is weaker than 1. When the distance between the amino group and carboxyl group in the amino acid moiety is increased, in the cases of /?-alanine 81 and y-aminobutyric acid 8m, the antifungal activity falls. TV-Substituted analogs, 8n and 8o, and sulfonic acid analog, 8p, in place of carboxylic acid, have no antifungal activity. The reduction of amido carbonyl at the C-15 position leads to a completely inactive alkyl amino analog 9. Methyl imino ether 4, which has a D-alanine residue similar to 9, shows no antifungal activity. Wehave synthesized a number of benanomicin analogs through an important intermediate 6 and evaluated their antifungal activities in vitro. The present study provides the first chemical transformation of the amino acid moiety of 1, which can be used in further derivatization.
The antifungal activity of benanomicins entirely depends on the structure of the amino acid side chain. The structural requirements of the side chain at the C-15 position These structural features necessary for the amino acid might control the binding to fungal cell surface. Fromresults mentioned above, we presumethat the steric and electrostatic interactions amongthe phenolic hydroxyl at C-l position, carbonyl in amido and terminal carboxyl group fix the conformation of the amino acid residue and the conformation plays an important role for the binding to fungi and the occurrence of the antifungal activity of 1. (Fig. 2) Experimental General Mass spectra (FAB-MS) were measured on a Jeol JMX-SX102 mass spectrometer. XH and 13C NMR spectra were recorded on a Jeol JNM-GX400 spectrometer at 50°C unless otherwise noted. (2) To a solution of 1 (3.0g) in a mixture of DMF (50ml) and MeOH (50ml) was added diazodiphenylmethane (1. 1 g). After stirring overnight, the solution was concentrated to half volume. To this was added water (200 ml). The dark red precipitates were collected by filtration and washed with ethyl acetate (200ml) and water (200ml). Diphenylmethyl ester of 1 (3.0 g) was obtained in 83% yield. Negative FAB-MSm/z 993 (M~). This ester (3.0 g) was acetylated with acetic anhydride (6ml) in pyridine (120ml) at 50°C for 3 hours. After concentration, the obtained syrup was treated with water (100 ml) to give yellow solid, which was washed with water. Compound2 (4.1 g) was obtained as an yellow powder quantitatively.
Nona-O-acetylbenanomicin A Diphenylmethyl Ester
Negative FAB-MS m/z 1,370 ((M-H)~).
Hepta-O-acetylbenanomicin Methyl Imino Ethers (3a~3c)
To a solution of 2 (4.2g) in anhydr dichloromethane (80ml) was added trimethyloxonium tetrafluoroborate (2.3 g). After stirring overnight at room temperature, a satd aq solution of NaHCO3(100 ml) was added. After 30minutes, the organic layer was washed by 5%aq citric acid solution and water, dried over anhydr MgSO4and concentrated under reduced pressure to give a mixture of hepta-O-acetyl-imino ethers (3a~3c). For the chemical and biological analysis, a part of the mixture was chromatographed on silica gel with hexane -ethyl acetate (2 : 3) to give diphenylmethyl ester 3a, methyl ester 3b and carboxylic acid 3c in 3 : 1 : 5 ratio. 3a: Negative FAB-MSm/z 1,300 ((M-H)"). XHNMR(CDC13, ambient tempera- Benanomicin A Methyl Imino Ether (4) The mixture of acetyl-imino ethers (3a~3b) (3.9g) was treated with 1 m NaOH(40ml) in MeOH (40ml) at room temperature overnight. After evaporation ofMeOH,1 m HC1was added to the solution to pH 1.6. An orange solid was precipitated, which was collected by centrifugation and washed with water and dried. Imino ether 4 (2. 1 g) was obtained. This compound was used in the next reaction without further purification. Compound4 was purified on silica gel column for preparing an analytical sample. Negative Desalaninebenanomicin A (6) Desalanine-methyl ester 5 (640mg) was treated with 1.6m NaOH in aq MeOH (64ml) at 70°C for 24hours. After acidification with 3m HC1to pH 1.6 in an ice bath, the precipitates were collected by nitration. The obtained solid was chromatographed on silica gel with chloroform -butanol -pyridine -water (4: 3 : 5 : 1) to give 6 as a pyridinium salt. The product was dissolved in water (50ml), acidified with 1 m HC1 to pH 1.6. The precipitates were collected by centrifugation to give 6 (430mg). 
Nona-O-acetyldesalaninebenanomicin A (7)
Compound 6 (640mg) was acetylated with acetic anhydride (5 ml) in pyridine (10ml). After 3 hours at 70°C, the solution was concentrated to solid which was chromatographed on silica gel with chloroform-MeOH-water (1000 : 20 : 1) to give nonaacetate 7 (643 mg). Negative FAB-MS mlz 1,134 (M~).
(2/tS>,3/^)-3/-Hydroxy-3/-methylbenanomicin A (8d) (L-Thr Analog) To a solution of 7 (lOOmg) and HOBT(74mg) in acetonitrile (4ml) were added a solution of L-threonine diphenylmethyl ester /?-toluenesulfonate (168mg) and 7V-methylmorpholine (60fA) in acetonitrile (3ml) and DCC(57mg) at 4°C. After 4hours at room temperature, acetic acid (0.2ml) was added. Precipitates were filtered and the filtrate was concentrated to solid. The solid was dissolved in ethyl acetate (20ml) and the solution was washed with 10% citric acid solution, satd NaHCO3solution and water, dried over anhydr MgSO4and evaporated to give the product (130mg). The product was treated with 0.2m aq K2CO3 in a mixture of MeOH(5 ml) and pyridine (3 ml) at 70°C overnight. After acidifying with 1 m HC1to pH 2.0, precipitates were collected by centrifugation and chromatographed on silica gel with chloroform -butanol -pyridine -water (40 : 20 : 25 : 3). The obtained pyridinium salt was dissolved in water and the pH of the solution was adjusted to pH 2.0 with 2mHC1. Precipitates were collected by OCT. 1992 centrifugation, washed with water and dried to give 8d (12mg). Negative FAB-MSm/z 857 (M ). *H NMR (DMSO-d6) d 1.22 (3/-CH3), 4.19 (3'-H), 4.44 (2'-H) and 7.76 (NH). 13C NMR S 171.7 (C-l'), 167.3 (C-l5), 66.4 (C-3' ), 58.0 (C-2' ) and 20.2 (3' -CH3).
Benanomicin A and Amino Acid Analogs of Benanomicin A (1, 8a~8c, 8e~8h, 8j~81, 8n and 8o) These compoundswere prepared by a similar procedure used for 8d.
Benanomicin A (1) (40 mg 2'-Carboxy-2'-demethylbenanomicin A (8j, aminomalonic acid analog) disodium salt (38 mg) was prepared from 7 (100 mg) and aminomalonic acid diethyl ester hydrochloride (77 mg). Negative FAB-MS m/z 901 ((M+2Na-2H)~, disodium salt). *H NMR (D2O, 70°C) <5 3.81 (2'-H). 13C NMR S 115A and 172.0 (each CO2H) and 72.4 (C-2' ).
2'-Demethylbenanomicin
A (8k, Gly analog) (46 mg) was prepared from 7 (lOO mg) and glycine ethyl ester hydrochloride (66mg). The properties of 8k were identical with natural product in all respects.6) A^-(2-Carboxyethyl)desalaninebenanomicin A-amide (81, /?-Ala analog) (41 mg) was prepared from 7 (80mg) and^-alanine methyl ester trifluoroacetate (57mg). Negative FAB-MSm/z 827 (M"). *H NMR (DMSO-4) S 2.52 (3' -H), 3.46 (3' -H) and 8.ll (NH). 13C NMR S 172.5 (C-l' ), 167.1 (C-15), 35.0 (C-3' ) and 33.6 (C-2').
2'-Demethyl-Af-methylbenanomicin A (8n, Sar analog) (19mg) was prepared from 7 (80mg) and sarcosine ethyl ester hydrochloride (45mg). Negative FAB-MS m/z 827 (M"). lH NMR(DMSCW6) 5 2.80 and 2.92 (N-CH3, rotamer) and 3.81 and 3.87 (2'-H, rotamer) . 13C NMR6 170.2 (C-l'), rotamer 7V,7V-dicyclohexylamine salt (200 mg) in a mixture of acetonitrile (0.27 ml) and water (0.45 ml). After stirring for 3 days at room temperature, 1 m aq K2CO3(4ml) and MeOH(4ml) were added to the reaction solution.
Acidification of the solution with 1 m HC1to pH 1.6, followed by centrifugation afforded a red solid. The solid was chromatographed on silica gel.with chloroform-butanol-pyridine -water (4 : 3 : 5 : 1) to give a product. The product was reprecipitated by the similar procedure to 8d to give D-serine analog 8i (15 mg). The properties of 8i were identical with the natural antibiotic in all respects.7)
A^-(3 -Carboxypropyl)desalaninebenanomicin A-amide (8m, GABAAnalog) y-Aminobutyric acid analog 8m (7mg) was prepared from 7 (65mg) and y-aminobutyric acid tetra-butylammonium salt (70mg) by the similar procedure to 81. Negative FAB-MSm/z 841 (M~). *H NMR (DMSO-d6) S 1.76 (3' -H), 2.32 (2' -H), 3.25 (4' -H) and 8.10 (NH). 13C NMR S 173.9 (C-l' ), 167.0 (C-15), 38.1 (C-4' ), 31.0 (C-2' ) and 24.4 (C-3' ).
A^-(Sulfomethyl)desalaninebenanomicin
A-amide (8p, Aminomethanesulfonic Acid
Compound 8p (10mg) was prepared from 7 (lOOmg) and aminomethanesulfonic acid tetrabutylammonium salt (129 mg) with HOBT(74 mg) and water soluble l-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (53mg) in DMFby the similar work up to 8i. Negative FAB-MSm/z 849 (M"). *H NMR(sodium salt, D2O, 70°C) 5 4.63 (l'-H). 13C NMR S 173.2 (C-15) and 57.1 (C-l').
1 5-Deoxobenanomicin A (9) To a solution of4 sodium salt (73mg) in aq EtOH (6ml) was added a solution ofNaBH4 (21 mg) in EtOH (0.5ml) at -30°C. After stirring for 4hours at this temperature, the solution was concentrated to solid. The residue was chromatographed on silica gel with chloroform -butanol -pyridine -water (4 : 4 : 7 : 2) to give a product. The product was dissolved in water (10ml). The solution was acidified with 2m HC1 to pH 2.0. Precipitates were collected by centrifugation to give 9 hydrochloride (8 mg). Negative FAB-MS m/z 813 (MT). *H NMR (DMSO-d6) S 1.53 (3'-H), 4.00 (2'-H) and 4.22 (15-H). 13C NMR S 170.8 (C-l'), 55.9 (C-2' ), 43.3 (C-15) and 16.2 (C-3' ).
Antifungal Activity MICson a glucose -nutrient agar were determined by the 2-fold agar dilution method after incubation at 27°C for 42hours according to the method described in a preceding paper.3)
